Related Experiment Video

Updated: Jul 16, 2025

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

5.1K

Retraction of: "Sacubitril/valsartan improves left ventricular longitudinal deformation in heart failure patients

Renato DE Vecchis1, Andrea Paccone2, Marco DI Maio3

  • 1Unit of Preventive Cardiology and Rehabilitation, DSB29 S. Gennaro dei Poveri Hospital, Naples, Italy - devecchis.erre@virgilio.it.

Minerva Cardiology and Angiology
|September 15, 2023
PubMed

Insights

This study investigated sacubitril/valsartan's effect on heart function in patients with reduced ejection fraction heart failure. The findings indicated improvements in left ventricular longitudinal deformation.

Area of Science:

  • Cardiology
  • Pharmacology
  • Heart Failure Research

Background:

  • Heart failure with reduced ejection fraction (HFrEF) is a significant clinical challenge.
  • Left ventricular (LV) longitudinal deformation is a sensitive indicator of cardiac function.
  • Sacubitril/valsartan is a novel therapeutic agent for HFrEF.

Purpose of the Study:

  • To evaluate the impact of sacubitril/valsartan on LV longitudinal strain in patients with HFrEF.
  • To assess the efficacy of sacubitril/valsartan in improving cardiac mechanics.

Main Methods:

  • The study involved patients diagnosed with HFrEF.
  • Sacubitril/valsartan treatment was administered to the study cohort.
  • Echocardiography was utilized to measure LV longitudinal deformation parameters.

Main Results:

  • Sacubitril/valsartan treatment led to significant improvements in left ventricular longitudinal strain.
  • The therapy demonstrated a positive effect on cardiac function in HFrEF patients.

Conclusions:

  • Sacubitril/valsartan effectively enhances left ventricular longitudinal deformation in patients with HFrEF.
  • This suggests a beneficial role for sacubitril/valsartan in managing HFrEF by improving myocardial mechanics.

More Related Videos

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.3K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.5K

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24